RxDoctor Payments Data

Rachael McAfee

Physician Assistant · Canoga Park, CANPI 1861495798

Payments from drug & device makers

$4,112in general payments, 2019–2025

Across 191 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mannkind Corporation$801
  • Novo Nordisk$570
  • Lilly USA, LLC$512
  • Boehringer Ingelheim$471
  • Dexcom, Inc.$418
  • Abbott$264
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$4,112100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,112 in reported general payments places this provider in the 90th percentile of 10,423 physician assistant providers in California.

See all physician assistant providers in California

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin203$220,370
OzempicSemaglutide117$132,063
TrulicityDulaglutide76$97,420
FarxigaDapagliflozin Propanediol74$72,665
MounjaroTirzepatide41$57,759
RybelsusSemaglutide28$46,580
TradjentaLinagliptin35$36,241
Tresiba Flextouch U-100Insulin Degludec45$32,139
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$29,139
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/747$27,839
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog48$22,827
JanuviaSitagliptin Phosphate27$18,700
DapagliflozinDapagliflozin Propanediol20$11,036
Humalog Kwikpen U-100Insulin Lispro36$10,507
Humulin R U-500 KwikpenInsulin Regular, Human12$9,741

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$471$256,610238 claims
Novo NordiskOzempic, Rybelsus, Novolog$570$181,990158 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog, Insulin Lispro$512$162,274159 claims
AstraZenecaFarxiga$80$72,66574 claims
Sanofi-aventis U.S. LLCAdmelog$103$3,06213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 10,423 physician assistant providers in California.

Other physician assistant in Canoga Park

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →